These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35455403)

  • 1. Improvement of Biocatalytic Properties and Cytotoxic Activity of L-Asparaginase from
    Dobryakova NV; Zhdanov DD; Sokolov NN; Aleksandrova SS; Pokrovskaya MV; Kudryashova EV
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activity and antiproliferative effect].
    Pokrovskaia MV; Pokrovskiĭ VS; Aleksandrova SS; Anisimova NIu; Adrianov RM; Treshchalina EM; Ponomarev GV; Sokolov NN
    Biomed Khim; 2013; 59(2):192-208. PubMed ID: 23789346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
    Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
    Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from
    Plyasova AA; Pokrovskaya MV; Lisitsyna OM; Pokrovsky VS; Alexandrova SS; Hilal A; Sokolov NN; Zhdanov DD
    Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 33008089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PEG-chitosan branched copolymers to improve the biocatalytic properties of Erwinia carotovora recombinant L-asparaginase].
    Kudryashova EV; Suhoverkov KV; Sokolov NN
    Biomed Khim; 2015; 61(4):480-7. PubMed ID: 26350739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functional regions in the Rhodospirillum rubrum L-asparaginase by site-directed mutagenesis.
    Pokrovskaya MV; Aleksandrova SS; Pokrovsky VS; Veselovsky AV; Grishin DV; Abakumova OY; Podobed OV; Mishin AA; Zhdanov DD; Sokolov NN
    Mol Biotechnol; 2015 Mar; 57(3):251-64. PubMed ID: 25370827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of telomerase activity leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase].
    Pokrovskaya MV; Zhdanov DD; Eldarov MA; Aleksandrova SS; Veselovskiy AV; Pokrovskiy VS; Grishin DV; Gladilina JA; Sokolov NN
    Biomed Khim; 2017 Jan; 63(1):62-74. PubMed ID: 28251953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodospirillum rubruml-asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition.
    Zhdanov DD; Pokrovsky VS; Pokrovskaya MV; Alexandrova SS; Eldarov MA; Grishin DV; Basharov MM; Gladilina YA; Podobed OV; Sokolov NN
    Biochem Biophys Res Commun; 2017 Oct; 492(2):282-288. PubMed ID: 28837806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of telomerase activity and induction of apoptosis by Rhodospirillum rubrum L-asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes.
    Zhdanov DD; Pokrovsky VS; Pokrovskaya MV; Alexandrova SS; Eldarov MA; Grishin DV; Basharov MM; Gladilina YA; Podobed OV; Sokolov NN
    Cancer Med; 2017 Nov; 6(11):2697-2712. PubMed ID: 28984046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross-immunogenicity of various bacterial L-asparaginases].
    D'iakov IN; Pokrovskiĭ VS; Sannikova EP; Bulushova NV; Pokrovskaia MV; Aleksandrova SS
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):100-4. PubMed ID: 25816523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-chitosan and glycol-chitosan for improvement of biopharmaceutical properties of recombinant L-asparaginase from Erwinia carotovora.
    Sukhoverkov KV; Kudryashova EV
    Biochemistry (Mosc); 2015 Jan; 80(1):113-9. PubMed ID: 25754046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.
    Parmentier JH; Maggi M; Tarasco E; Scotti C; Avramis VI; Mittelman SD
    Leuk Res; 2015 Jul; 39(7):757-62. PubMed ID: 25941002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia.
    Vieira Pinheiro JP; Müller HJ; Schwabe D; Gunkel M; Casimiro da Palma J; Henze G; von Schütz V; Winkelhorst M; Würthwein G; Boos J
    Br J Haematol; 2001 Apr; 113(1):115-9. PubMed ID: 11328290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Active Thermophilic L-Asparaginase from
    Dumina M; Zhgun A; Pokrovskaya M; Aleksandrova S; Zhdanov D; Sokolov N; El'darov M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding targets for a metabolic therapy of cancer: L-asparaginase.
    Covini D; Tardito S; Bussolati O; Chiarelli LR; Pasquetto MV; Digilio R; Valentini G; Scotti C
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):4-13. PubMed ID: 21854356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.
    Chien WW; Allas S; Rachinel N; Sahakian P; Julien M; Le Beux C; Lacroix CE; Abribat T; Salles G
    Invest New Drugs; 2014 Oct; 32(5):795-805. PubMed ID: 24829072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncovalent PEGylation of L-asparaginase using PEGylated polyelectrolyte.
    Kurinomaru T; Shiraki K
    J Pharm Sci; 2015 Feb; 104(2):587-92. PubMed ID: 25354692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
    Avramis VI; Tiwari PN
    Int J Nanomedicine; 2006; 1(3):241-54. PubMed ID: 17717965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.